All In Biotech

Drug Trial Radar · NCT06700343

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

A Randomized, Double-blind Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics, and Clinical Effects Between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects With Relapsing-remitting Multiple Sclerosis

Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 152 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

152

Actual

Start

Jan 13, 2025

Primary completion

Apr 19, 2027

Study completion Oct 4, 2027

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Nov 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Main objectives of the study are to demonstrate pharmacokinetic (PK) similarity between ABP 692 and ocrelizumab (US), as well as between ABP 692 and ocrelizumab (EU).

Conditions

  • Relapsing-remitting Multiple Sclerosis (RRMS)

Interventions

  • Ocrelizumab (US)Drug

    IV infusion

  • Ocrelizumab (EU)Drug

    IV infusion

  • ABP 692Drug

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Serum Concentration-time Curve (AUC) From Time 0 to Day15 (AUC0-d15) Following Infusion 1 ofthe Initial Dose of InvestigationalProduct (IP)Time frame: Day 1 to Day 15
  2. AUC From Time 0 Extrapolated toInfinity (AUC0-inf) of the Entire Initial Dose of IPTime frame: Day 1 to Week 16

Locations

109 sites in 22 countries. Site status is shown where the registry gives one.

  • University of South Alabama

    Mobile, Alabama

  • Clinical Endpoints, LLC

    Scottsdale, Arizona

  • Profound Research - Neurology Center of Southern California

    Carlsbad, California

  • Mountain Neurological Research Center

    Basalt, Colorado

  • Advanced Neurosciences Research, Llc

    Fort Collins, Colorado

  • Hasbani Neurology

    New Haven, Connecticut

  • Neurology Offices of South Florida

    Boca Raton, Florida

  • Aqualane Clinical Research

    Naples, Florida

  • Emerald Coast Neurology/Synergy Clinical Research

    Pensacola, Florida

  • Knight Neurology

    Rockledge, Florida

  • Premiere Research Institute Palm Beach

    West Palm Beach, Florida

  • Hawaii Pacific Neuroscience

    Honolulu, Hawaii

  • Rush University Medical Center, Rush University Cancer Center

    Chicago, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Henry Ford Health

    Detroit, Michigan

  • Michigan Institute For Neurological Disorders (Glendale Neurological Associates) - Farmington Hills

    Farmington, Michigan

  • JFK Medical Center

    Edison, New Jersey

  • Hackensack Meridian Health

    Paramus, New Jersey

  • University of NM/Mind Imaging center

    Albuquerque, New Mexico

  • Triad Neurological Associates

    Winston-Salem, North Carolina

  • Singlepoint Healthcare Opco, LLC

    Columbus, Ohio

  • NDx Clinical Research, Inc

    Dayton, Ohio

  • Premier Neurology, PC

    Greenville, South Carolina

  • Hope Neurology

    Knoxville, Tennessee

  • Vanderbilt University Medical Center (VUMC)

    Nashville, Tennessee

  • Lone Star Neurology

    Frisco, Texas

  • Froedtert Hospital-Medical College of Wisconsin

    Milwaukee, Wisconsin

  • MS-Netwerk Limburg - Revalidatie & MS Centrum

    Overpelt, Belgium

  • Algemeen Ziekenhuis Delta

    Roeselare, West-Vlaanderen, Belgium

  • UMHAT Dr.Georgi Stranski EAD

    Pleven, Bulgaria

  • University Multi-Profile Hospital for Active Treatment (UMHAT) St. Ivan Rilski

    Sofia, Bulgaria

  • Medical Center Hera EOOD

    Sofia, Bulgaria

  • UMHATEM N.I. Pirogov

    Sofia, Bulgaria

  • Diagnostic Consultative Center Convex Ltd

    Sofia, Sofiiska, Bulgaria

  • Foothills Medical Centre

    Calgary, Alberta, Canada

  • The Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

  • Sestre milosrdnice University Hospital Center

    Zagreb, Croatia

  • University Hospital Centre Zagreb

    Zagreb, Croatia

  • Fakultni nemocnice u sv. Anny v Brne

    Brno, Czechia

  • Fakultni Nemocnice Hradec Kralove

    Hradec Králové, Czechia

Showing 40 of 109 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.